title: CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design.
authors.affiliation: Imperial College, Hammersmith Campus, London, UK. k.rezvani@imperial.ac.uk
authors.forename: Katayoun
authors.initials: K
authors.lastname: Rezvani
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D023201:CD40 Ligand / Q000235:genetics / Q000378:metabolism; D019496:Cancer Vaccines; D018274:Electroporation; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular / Q000235:genetics; D007167:Immunotherapy; D007376:Interleukin-2 / Q000235:genetics / Q000378:metabolism; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D058408:Th1-Th2 Balance; D019076:Transgenes / Q000235:genetics; D014182:Transplantation, Autologous
chemical_list: D019496:Cancer Vaccines; D007376:Interleukin-2; D023201:CD40 Ligand